Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Alterations of the Birt-Hogg-Dubé gene (BHD) in sporadic colorectal tumours.

Kahnoski K, Khoo SK, Nassif NT, Chen J, Lobo GP, Segelov E, Teh BT.

J Med Genet. 2003 Jul;40(7):511-5. No abstract available.

2.

Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.

da Silva NF, Gentle D, Hesson LB, Morton DG, Latif F, Maher ER.

J Med Genet. 2003 Nov;40(11):820-4.

3.

Mutations of the Birt-Hogg-Dubé (BHD) gene in sporadic colorectal carcinomas and colorectal carcinoma cell lines with microsatellite instability.

Shin JH, Shin YK, Ku JL, Jeong SY, Hong SH, Park SY, Kim WH, Park JG.

J Med Genet. 2003 May;40(5):364-7. No abstract available.

4.

Clinical and genetic studies of Birt-Hogg-Dubé syndrome.

Khoo SK, Giraud S, Kahnoski K, Chen J, Motorna O, Nickolov R, Binet O, Lambert D, Friedel J, Lévy R, Ferlicot S, Wolkenstein P, Hammel P, Bergerheim U, Hedblad MA, Bradley M, Teh BT, Nordenskjöld M, Richard S.

J Med Genet. 2002 Dec;39(12):906-12. Erratum in: J Med Genet. 2003 Feb;40(2):150..

5.

Investigation of the Birt-Hogg-Dube tumour suppressor gene (FLCN) in familial and sporadic colorectal cancer.

Nahorski MS, Lim DH, Martin L, Gille JJ, McKay K, Rehal PK, Ploeger HM, van Steensel M, Tomlinson IP, Latif F, Menko FH, Maher ER.

J Med Genet. 2010 Jun;47(6):385-90. doi: 10.1136/jmg.2009.073304.

PMID:
20522427
6.

Most microsatellite unstable sporadic colorectal carcinomas carry MBD4 mutations.

Bader S, Walker M, Harrison D.

Br J Cancer. 2000 Dec;83(12):1646-9.

7.

Birt-Hogg-Dubé (BHD) gene mutations in human gastric cancer with high frequency microsatellite instability.

Jiang W, Fujii H, Matsumoto T, Ohtsuji N, Tsurumaru M, Hino O.

Cancer Lett. 2007 Apr 8;248(1):103-11.

PMID:
16870330
8.

[p53 mutations in sporadic colorectal cancers with microsatellite instability].

Huang J, Zheng S, Pan QR, Deng YC.

Zhonghua Yi Xue Za Zhi. 2003 Jul 10;83(13):1130-3. Chinese.

PMID:
12921629
9.

Inactivation of BHD in sporadic renal tumors.

Khoo SK, Kahnoski K, Sugimura J, Petillo D, Chen J, Shockley K, Ludlow J, Knapp R, Giraud S, Richard S, Nordenskjöld M, Teh BT.

Cancer Res. 2003 Aug 1;63(15):4583-7.

10.

Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome.

Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner ML, Duray P, Merino M, Choyke P, Pavlovich CP, Sharma N, Walther M, Munroe D, Hill R, Maher E, Greenberg C, Lerman MI, Linehan WM, Zbar B, Schmidt LS.

Cancer Cell. 2002 Aug;2(2):157-64.

11.

CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation.

Pilozzi E, Onelli MR, Ziparo V, Mercantini P, Ruco L.

J Pathol. 2004 Nov;204(3):289-95.

PMID:
15378566
12.

Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.

Popović Hadzija M, Radosevic S, Kovacević D, Lukac J, Hadzija M, Spaventi R, Pavelić K, Kapitanović S.

Mutat Res. 2004 Apr 14;548(1-2):61-73.

PMID:
15063137
13.

Analysis of SMAD4/DPC4 gene alterations in multiploid colorectal carcinomas.

Ando T, Sugai T, Habano W, Jiao YF, Suzuki K.

J Gastroenterol. 2005 Jul;40(7):708-15.

PMID:
16082587
14.

High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors.

Vocke CD, Yang Y, Pavlovich CP, Schmidt LS, Nickerson ML, Torres-Cabala CA, Merino MJ, Walther MM, Zbar B, Linehan WM.

J Natl Cancer Inst. 2005 Jun 15;97(12):931-5. Erratum in: J Natl Cancer Inst. 2005 Jul 20;97(14):1096.

PMID:
15956655
15.

Identification and characterization of Birt-Hogg-Dubé associated renal carcinoma.

Murakami T, Sano F, Huang Y, Komiya A, Baba M, Osada Y, Nagashima Y, Kondo K, Nakaigawa N, Miura T, Kubota Y, Yao M, Kishida T.

J Pathol. 2007 Apr;211(5):524-31.

PMID:
17323425
16.
17.

Loss of heterozygosity and mutational analyses of the ACTRII gene locus in human colorectal tumors.

Olaru A, Mori Y, Yin J, Wang S, Kimos MC, Perry K, Xu Y, Sato F, Selaru FM, Deacu E, Sterian A, Shibata D, Abraham JM, Meltzer SJ.

Lab Invest. 2003 Dec;83(12):1867-71.

PMID:
14691305
18.

Alterations in the tissue inhibitor of metalloproteinase-3 (TIMP-3) are found frequently in human colorectal tumours displaying either microsatellite stability (MSS) or instability (MSI).

Brueckl WM, Grombach J, Wein A, Ruckert S, Porzner M, Dietmaier W, Rümmele P, Croner RS, Boxberger F, Kirchner T, Hohenberger W, Hahn EG, Jung A.

Cancer Lett. 2005 Jun 1;223(1):137-42.

PMID:
15890246
19.

Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines.

Ku JL, Kang SB, Shin YK, Kang HC, Hong SH, Kim IJ, Shin JH, Han IO, Park JG.

Oncogene. 2004 Sep 2;23(40):6736-42.

PMID:
15273736
20.

Impairment of stromelysin-1 transcriptional activity by promoter mutations in high microsatellite instability colorectal tumors.

Morán A, Iniesta P, de Juan C, García-Aranda C, Díaz-López A, Benito M.

Cancer Res. 2005 May 1;65(9):3811-4.

Items per page

Supplemental Content

Support Center